France· FR:67237394
IOPAMIRON 370 (370 mg d'Iode par mL), solution injectable
A iopamidol product containing iopamidol, registered in France by BRACCO IMAGING FRANCE. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Iopamidol is registered in 12 of 19 countries.
Countries holding a registration under ATC V08AB04 (iopamidol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Iopamidol · ATC V08AB04
12 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IOPAMIDOL
- Manufacturer
- BRACCO IMAGING FRANCE
- Country
- France (FR)
- ATC code
- V08AB04
- ATC class
- Iopamidol
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 6
- cip1334009301487301 flacon(s) en verre de 100 ml avec nécessaire d'administration pour injecteur CT-Exprès (set patient (polyméthacrylate butadiène styrène), perforateur (polyméthacrylate butadiène styrène) et cathéter IV (BD Insyte Autoguard ou B.Braun Vasofix Safety))
- cip1334009302822981 flacon(s) en verre de 500 ml
- cip1334009324594381 flacon(s) en verre de 50 ml
- cip1334009324596671 flacon(s) en verre de 100 ml
- cip1334009324597281 flacon(s) en verre de 200 ml
- cip1334009339836801 flacon(s) en verre de 100 ml avec nécessaire d’administration (seringue (polyéthylène téréphtalate, polycarbonate), tubulure (PVC), perforateur et cathéter IV (BD Insyte Autoguard ou B.Braun Vasofix Safety))
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for iopamidol.
Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iopamidol · interactions on record
367 records
- 286 severe
- 54 moderate
- 27 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iopamidol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGastromiro 612.4mg/ml solution 100ml bottlesBracco UK Ltd
- Japanイオパミドールバイエル薬品
- GermanyIopamidol Consentis DiagnosticsConsentis Diagnostics Gmbh
- United StatesiopamidolSlate Run Pharmaceuticals, LLC
- SwitzerlandScanlux 300 mg/ml, Injektionslösungb.e.imaging.ag
- FinlandIopamidol GenericsGwent Medicinal Products Ltd.
- BelgiumIopamidol Bracco Imaging 150 mg/mlBracco Imaging
- CanadaISOVUE 200 INJECTIONBRACCO IMAGING CANADA
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Gastromiro, Iopavision
- Bulgaria · Scanlux, Йопамиро
- Germany · Iopamidol Consentis Diagnostics, Iopamiro
- Estonia · Iopamiro
- Spain · Iopamiro, Scanlux
- United Kingdom (Northern Ireland) · Gastromiro, Niopam
- Greece · Iopamiro, Iopamiro 300
- Croatia · Iopamiro
- Hungary · Iopamiro, Scanlux
- Ireland · Gastromiro, Niopam
- Italy · Gastromiro, Iopamiro
- Lithuania · Iopamiro
- Netherlands · Iopamidol Adoh
- Portugal · Gastromiro, Iopamiro
- Romania · Iopamiro
- Slovenia · Gastromiro, Iopamiro
- Slovakia · Scanlux
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eaa680e1-9ea1-4aaf-9b3d-b9e90da03dfe GET /v1/drugs/eaa680e1-9ea1-4aaf-9b3d-b9e90da03dfe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67237394",
"date_amm": "1981-05-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "IOPAMIDOL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intra-utérine;intraartérielle;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about iopamidol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.